tiprankstipranks
Trending News
More News >
Boston Scientific (CH:BSX)
:BSX
Switzerland Market
Advertisement

Boston Scientific (BSX) Stock Forecast & Price Target

Compare
0 Followers
See the Price Targets and Ratings of:

BSX Analyst Ratings

Currently, no data available
Based on NaN analysts giving stock ratings to
Boston
Scientific
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

BSX Stock 12 Month Forecast

There Are No Analyst Ratings for CH:BSX In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

BSX Financial Forecast

BSX Earnings Forecast

Next quarter’s earnings estimate for BSX is $0.62 with a range of $0.60 to $0.63. The previous quarter’s EPS was $0.60. BSX beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year BSX has Preformed in-line its overall industry.
Next quarter’s earnings estimate for BSX is $0.62 with a range of $0.60 to $0.63. The previous quarter’s EPS was $0.60. BSX beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year BSX has Preformed in-line its overall industry.

BSX Sales Forecast

Next quarter’s sales forecast for BSX is $4.20B with a range of $4.15B to $4.24B. The previous quarter’s sales results were $4.03B. BSX beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year BSX has Preformed in-line its overall industry.
Next quarter’s sales forecast for BSX is $4.20B with a range of $4.15B to $4.24B. The previous quarter’s sales results were $4.03B. BSX beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year BSX has Preformed in-line its overall industry.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays Analyst forecast on CH:BSX
Barclays
Barclays
CHF108.41
Buy
Reiterated
10/24/25
Boston Scientific (BSX) Gets a Buy from Barclays
Truist Financial Analyst forecast on CH:BSX
Truist Financial
Truist Financial
CHF102.83CHF103.63
Buy
Reiterated
10/23/25
Truist Financial Remains a Buy on Boston Scientific (BSX)
Jefferies
CHF103.63CHF105.22
Buy
Reiterated
10/23/25
Jefferies Sticks to Their Buy Rating for Boston Scientific (BSX)
Citi
CHF99.64CHF103.63
Buy
Reiterated
10/23/25
Citi Remains a Buy on Boston Scientific (BSX)
Wells Fargo Analyst forecast on CH:BSX
Wells Fargo
Wells Fargo
CHF98.85CHF99.64
Buy
Reiterated
10/23/25
Boston Scientific price target raised to $125 from $124 at Wells FargoBoston Scientific price target raised to $125 from $124 at Wells Fargo
Leerink Partners Analyst forecast on CH:BSX
Leerink Partners
Leerink Partners
CHF102.03CHF103.63
Buy
Reiterated
10/23/25
We are reiterating our Outperform rating on BSX and increasing our PT to $130 (from $128).
Canaccord Genuity Analyst forecast on CH:BSX
Canaccord Genuity
Canaccord Genuity
CHF105.22
Buy
Reiterated
10/23/25
Canaccord Genuity Keeps Their Buy Rating on Boston Scientific (BSX)
UBS
CHF107.61CHF111.6
Buy
Reiterated
10/23/25
Boston Scientific: Strong Growth Trajectory and Attractive Valuation Drive Buy Rating
Morgan Stanley Analyst forecast on CH:BSX
Morgan Stanley
Morgan Stanley
CHF99.64CHF103.63
Buy
Reiterated
10/23/25
Boston Scientific price target raised to $130 from $125 at Morgan StanleyBoston Scientific price target raised to $130 from $125 at Morgan Stanley
TR | OpenAI - 4o Analyst forecast on CH:BSX
TR | OpenAI - 4o
TR | OpenAI - 4o
CHF93.27CHF94.06
Buy
Reiterated
10/23/25
AI Generated ArticleAI Generated Article
Bank of America Securities Analyst forecast on CH:BSX
Bank of America Securities
Bank of America Securities
CHF95.66
Buy
Reiterated
10/22/25
Boston Scientific's Strong Performance and Promising Outlook Justifies Buy Rating
TD Cowen
CHF91.67
Buy
Reiterated
10/22/25
Boston Scientific's Strong Financial Performance and Positive Outlook Earns Buy Rating
Evercore ISI Analyst forecast on CH:BSX
Evercore ISI
Evercore ISI
CHF87.69CHF90.08
Buy
Reiterated
10/22/25
Boston Scientific's Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating
Goldman Sachs Analyst forecast on CH:BSX
Goldman Sachs
Goldman Sachs
CHF95.66CHF98.85
Buy
Reiterated
10/22/25
Boston Scientific price target raised to $124 from $120 at Goldman SachsBoston Scientific price target raised to $124 from $120 at Goldman Sachs
RBC Capital
CHF99.64
Buy
Reiterated
10/22/25
RBC Capital Keeps Their Buy Rating on Boston Scientific (BSX)
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Barclays Analyst forecast on CH:BSX
Barclays
Barclays
CHF108.41
Buy
Reiterated
10/24/25
Boston Scientific (BSX) Gets a Buy from Barclays
Truist Financial Analyst forecast on CH:BSX
Truist Financial
Truist Financial
CHF102.83CHF103.63
Buy
Reiterated
10/23/25
Truist Financial Remains a Buy on Boston Scientific (BSX)
Jefferies
CHF103.63CHF105.22
Buy
Reiterated
10/23/25
Jefferies Sticks to Their Buy Rating for Boston Scientific (BSX)
Citi
CHF99.64CHF103.63
Buy
Reiterated
10/23/25
Citi Remains a Buy on Boston Scientific (BSX)
Wells Fargo Analyst forecast on CH:BSX
Wells Fargo
Wells Fargo
CHF98.85CHF99.64
Buy
Reiterated
10/23/25
Boston Scientific price target raised to $125 from $124 at Wells FargoBoston Scientific price target raised to $125 from $124 at Wells Fargo
Leerink Partners Analyst forecast on CH:BSX
Leerink Partners
Leerink Partners
CHF102.03CHF103.63
Buy
Reiterated
10/23/25
We are reiterating our Outperform rating on BSX and increasing our PT to $130 (from $128).
Canaccord Genuity Analyst forecast on CH:BSX
Canaccord Genuity
Canaccord Genuity
CHF105.22
Buy
Reiterated
10/23/25
Canaccord Genuity Keeps Their Buy Rating on Boston Scientific (BSX)
UBS
CHF107.61CHF111.6
Buy
Reiterated
10/23/25
Boston Scientific: Strong Growth Trajectory and Attractive Valuation Drive Buy Rating
Morgan Stanley Analyst forecast on CH:BSX
Morgan Stanley
Morgan Stanley
CHF99.64CHF103.63
Buy
Reiterated
10/23/25
Boston Scientific price target raised to $130 from $125 at Morgan StanleyBoston Scientific price target raised to $130 from $125 at Morgan Stanley
TR | OpenAI - 4o Analyst forecast on CH:BSX
TR | OpenAI - 4o
TR | OpenAI - 4o
CHF93.27CHF94.06
Buy
Reiterated
10/23/25
AI Generated ArticleAI Generated Article
Bank of America Securities Analyst forecast on CH:BSX
Bank of America Securities
Bank of America Securities
CHF95.66
Buy
Reiterated
10/22/25
Boston Scientific's Strong Performance and Promising Outlook Justifies Buy Rating
TD Cowen
CHF91.67
Buy
Reiterated
10/22/25
Boston Scientific's Strong Financial Performance and Positive Outlook Earns Buy Rating
Evercore ISI Analyst forecast on CH:BSX
Evercore ISI
Evercore ISI
CHF87.69CHF90.08
Buy
Reiterated
10/22/25
Boston Scientific's Strong Financial Performance and Strategic Growth Initiatives Justify Buy Rating
Goldman Sachs Analyst forecast on CH:BSX
Goldman Sachs
Goldman Sachs
CHF95.66CHF98.85
Buy
Reiterated
10/22/25
Boston Scientific price target raised to $124 from $120 at Goldman SachsBoston Scientific price target raised to $124 from $120 at Goldman Sachs
RBC Capital
CHF99.64
Buy
Reiterated
10/22/25
RBC Capital Keeps Their Buy Rating on Boston Scientific (BSX)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Boston Scientific

1 Month
xxx
Success Rate
22/28 ratings generated profit
79%
Average Return
+2.14%
reiterated a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 78.57% of your transactions generating a profit, with an average return of +2.14% per trade.
3 Months
xxx
Success Rate
18/22 ratings generated profit
82%
Average Return
+6.95%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 81.82% of your transactions generating a profit, with an average return of +6.95% per trade.
1 Year
Richard NewitterTruist Financial
Success Rate
23/25 ratings generated profit
92%
Average Return
+28.87%
reiterated a buy rating 3 days ago
Copying Richard Newitter's trades and holding each position for 1 Year would result in 92.00% of your transactions generating a profit, with an average return of +28.87% per trade.
2 Years
xxx
Success Rate
31/33 ratings generated profit
94%
Average Return
+49.82%
reiterated a xxx
rating 25 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 93.94% of your transactions generating a profit, with an average return of +49.82% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BSX Analyst Recommendation Trends

Rating
Jun 25
Jul 25
Aug 25
Sep 25
Oct 25
Strong Buy
0
0
0
0
0
Buy
48
57
47
58
47
Hold
1
1
1
1
1
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
49
58
48
59
48
In the current month, BSX has received 47 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. BSX average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.

BSX Stock Forecast FAQ

What is CH:BSX’s average 12-month price target, according to analysts?
Currently, no data Available
What is CH:BSX’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for CH:BSX, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is Boston Scientific a Buy, Sell or Hold?
      Currently, no data Available
      What is Boston Scientific’s share price target?
      Currently, no data Available
      What do analysts say about Boston Scientific?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of Boston Scientific?
      To buy shares of CH:BSX, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis